(NASDAQ: NUWE) Nuwellis's forecast annual revenue growth rate of 61.88% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.03%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.15%.
Nuwellis's revenue in 2026 is $9,008,000.On average, 3 Wall Street analysts forecast NUWE's revenue for 2026 to be $5,444,279, with the lowest NUWE revenue forecast at $5,231,160, and the highest NUWE revenue forecast at $5,604,389. On average, 3 Wall Street analysts forecast NUWE's revenue for 2027 to be $6,098,242, with the lowest NUWE revenue forecast at $5,859,159, and the highest NUWE revenue forecast at $6,277,825.
In 2028, NUWE is forecast to generate $23,452,322 in revenue, with the lowest revenue forecast at $22,532,771 and the highest revenue forecast at $24,141,984.